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The sequence of the glycolytic enzymatic reactions responsible for the breakdown of glucose into
two trioses and further into pyruvate or lactate was elucidated in 1940. For over seven decades
it has been taught precisely the way that sequence was first described by Embden, Meyerhof
and Parnas. Accordingly, two different glycolytic outcomes were proposed; the aerobic one with
pyruvate as the final product, and the anaerobic one, identical to aerobic glycolysis except for
one additional step, the reduction of pyruvate to lactate. While pyruvate has been presented as
the mitochondrial substrate of the tricarboxylic acid cycle, lactate has regularly been vilified as a
useless and frequently toxic end product of anaerobic glycolysis. Several studies in the 1980s have
shown that both muscle and brain tissues are capable of oxidizing and utilizing lactate as an energy
substrate, thus challenging the monocarboxylate’s ill reputation. Expectedly, these findings were
met with great skepticism and doubts that lactate could play any role in bioenergetics. Despite
many studies from the 1920s and 1930s that have clearly showed the ability of brain tissue to
oxidize lactate, even the investigators who published them assumed that lactate oxidation was
simply a clearing mechanism of this end-product of anaerobic glycolysis (Schurr, 2006, 2014).
Nevertheless, in the past two decades monocarboxylate transporters (MCTs) were identified and
localized in both cellular and mitochondrial membranes and the existence of a lactate receptor in
the brain has also been suggested (Bergersen and Gjedde, 2012). Both direct and indirect evidence
now indicate that the enzyme lactate dehydrogenase (LDH) resides not only in the cytosol, as
part of the glycolytic pathway machinery, but also in the mitochondrial outer membrane. The
mitochondrial form of the enzyme oxidizes lactate to pyruvate and concomitantly produces the
reducing agent NADH (Passarella et al., 2014; Rogatzki et al., 2015). These findings have shed light
on a major drawback of the originally proposed aerobic version of the glycolytic pathway i.e., its
inability to regenerate NAD+, in contrast to the anaerobic glycolysis that features a cyclical ability
to regenerate NAD+upon pyruvate reduction to lactate by the cytosolic LDH. The malate-aspartate
shuttle (MAS), a major redox shuttle in the brain was proposed as an alternative pathway for NAD+
generation for aerobic glycolysis. However, the necessity for MAS to fulfill such function could be
questioned if the glycolytic pathway always proceeded to its end-products, lactate and NAD+, or
when the suggested alternative, a lactate-malate-aspartate shuttle (Kane, 2014) is considered. An
additional dilemma the originally proposed aerobic glycolysis presents, has to do with the glycolytic
pathway of erythrocytes, which despite its highly aerobic environment always produces lactate as its
end-product. Meanwhile, several other functions have been suggested for lactate (Chambers et al.,
2014; Galow et al., 2014; Hertz et al., 2014; Brooks and Martin, 2015; Goodwin et al., 2015). For
decades, pyruvate has always been the substrate of choice whenmeasuring the rate of mitochondrial
State III respiration employing an oxygen electrode.However, only recently it has been shown
that lactate can be used as a substrate, too (de Bari et al., 2008; Passarella et al., 2008, 2014).
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Additional experiments could be designed to provide further
insight into the role of lactate in energymetabolism. For example,
would the addition of mitochondria to ruptured red blood cells
switch their glycolytic pathway to produce pyruvate instead of
lactate?
This Research Topic, now published as an E-book, includes
14 contributions from investigators conducting research in this
field who review, opine, comment, or publish original data.
In their perspective, Mariga et al. (2014) elaborate on the
role of lactate in cerebral malaria (CM). Based on the data
available, the authors suggest that monocarboxylate transporters
(MCTs) and the lactate receptor GPR81 could become novel
therapeutic targets in CM. Hertz et al. (2014), in their article,
review the different roles lactate plays in brain tissue, including
the modulation of glucose utilization rate, diagnosis of brain-
injured patients and mediation of redox and receptor signaling,
memory, and gene transcription. While these authors are
listing multiple roles for lactate, mainly involving gap junction-
coupled astrocytes, lactate’s direct role as an oxidative energy
substrate is not on the list. In his contribution, Schurr (2014)
has reviewed a great number of papers on muscle and brain
energy metabolism that werepublished in the waning years
of the 19th century and the first four decades or so of the
20th century, providing a historical perspective to narrate the
evolution of thinking and research in this field. These studies
were crucial in the formation of the dogma according to
which lactate, the end-product of anaerobic glycolysis, is useless
and at times, poisonous. Using Margolis’s (1993) concept that
“habits of mind” govern scientific beliefs, Schurr argues that
habits of mind still influence many scientists’ beliefs today
pertaining to lactate uselessness and the dissociation of glycolysis
into aerobic and anaerobic pathways. These “habits of mind”
persist, despite data already available in the 1920s and 1930s
demonstrating that the brain oxidizes lactate very efficiently. The
contribution of glycogen in supporting axon conduction both
in peripheral and central nervous systems, and the role lactate
plays in it, is reviewed by Chambers et al. (2014). The authors
suggest that the presence of significant steady concentration
of lactate in the periphery of both central white matter
and peripheral nerve under unstimulated baseline conditions
indicates a continuous eﬄux of lactate to the interstitium. They
argue for the reexamination of the “on demand” shuttling of
lactate between cellular elements based on the existence of those
lactate pools, and thus, offer a continuous lactate eﬄux surplus
available for immediate neural requirements. In a perspective
on lactate oxidation at the mitochondria, Kane (2014) put
forward the idea that shuttled lactate from the cytosol to the
mitochondrion operates in a manner very similar to the malate-
aspartate shuttle, the purpose of which has been proposed to
be the oxidation of lactate and a mitochondrial electron shuttle.
Moreover, he proposes that the two shuttles, the lactate one
and the malate-aspartate one, are necessarily interconnected.
Passarella et al. (2014) opine on the continuous debate
among scientists as to whether or not L-lactatedehydrogenase
(L-LDH) is localized in mitochondria. The debate goes on
despite the overwhelming evidence supporting the localization
of mitochondrial L-lactatedehydrogenase (m-L-LDH) inside
these organelles. The authors argue that m-L-LDH can be
detected in the mitochondrion when isolation and purification
procedures are carried out carefully such that mitochondria stay
coupled. Several measurements and assays can be easily and
persuasively be performed to ascertain the metabolism of lactate
in mitochondria. Goodwin et al. (2015), in an opinion article,
present a concise overview of some recent developments in
the field of lactate metabolism and cancer. Summarizing their
overview, the authors conclude that lactate is both a potent fuel
oxidatively and a signaling molecule involved in angiogenesis,
and that it can be generated and exported or imported by tumors.
They propose that lactate-protected hypoglycemia may be a
viable strategy in tumors that exhibit high lactate production
despite adequate tissue oxygen tension, while monocarboxylate
transporter inhibitors could be useful against tumors whose
angiogenesis is driven by lactate. In another opinion article,
Deitmer et al. (2015) provide a perspective on the role of lactate
as a signaling molecule and a modulator of metabolic processes
due to its cotransport with H+ via monocarboxylate transporters
(MCTs). Accordingly, lactate transporters form a “transport
metabolon” with carbonic anhydrases. Allaman et al. (2015)
review the existing knowledge on the cerebral glyoxalase system
in both astrocytes and neurons. These two cerebral cell types
with their high glycolytic activity presumably produce the highly
reactive dicarbonyl compound, methylglyoxal, as a by-product
of glycolysis. Methylglyoxal is associated with pathologies such
as diabetes and aging, although its neurotoxicity in the brain is
not well characterized. The authors advance a concept attributing
astrocytes and neurons differential adaptive glyoxalase defense
mechanisms against methylglyoxal-induced cellular damage.
Brooks and Martin (2015) review theirs and others’ studies
on the post traumatic brain injury (TBI) treatment. In their
studies, the authors compared dextrose + insulin treatment to
exogenous lactate infusion in TBI patients with intact hepatic
and renal functions, demonstrating that the latter results in
normal glycemia. Carpenter et al. (2015) also review the role of
lactate in TBI and the possible beneficial effect of intravenous
exogenous lactate supplementation to TBI patients. Zilberter
et al. (2015) opine in their paper on the potential of pyruvate,
the other glycolytic monocarboxylate, as the treatment for
signature characteristics of many neurological diseases i.e.,
hypometabolism, oxidative stress, and neuroinflamation. The
authors believe that pyruvate is an ideal candidate for the
treatment of these pathologies due to its unique combination of
neuroprotective properties.
In light of the wealth of information already available, as
can be gleaned from the present compilation of papers about
lactate and its central role in energy metabolism in most, if
not in all, tissues and specifically in the brain, it is clearly the
time to reexamine theoriginal dogma of glycolysis.The separation
of glycolysis into two distinct pathways, aerobic and anaerobic,
is outdated and misleading. The first metabolic pathway to be
elucidated 75 years ago should be redrawn as a singular pathway,
its substrate being glucose and its end-product being lactate, the
ultimate substrate of the mitochondrial TCA cycle.
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